Researchers are hoping the threat of Lyme disease could become a thing of the past.

Lyme disease infects hundreds of thousands of people each year and now scientists may be on the verge of a breakthrough with ...

The pharmaceutical companies Pfizer and Valneva say their vaccine shows promising results, as they seek Food and Drug ...

Pfizer's shot fell short of its trial goal, but with nearly half a million Americans infected each year, the company isn't ...

It’s rare to get such a massive high-yielder that’s also positioning itself for long-term growth. Of course, shares of Pfizer ...

In this week’s edition of InnovationRx, we look at a serial entrepreneur’s effort to build an FDA-approved AI doctor, ...

Topline results from the VALOR trial demonstrate the efficacy of a multivalent OspA vaccine candidate in preventing confirmed cases of Lyme disease.

The first human Lyme disease vaccine was 73% effective against the tick-borne illness, says Pfizer. They still plan to seek ...

Scientists found that the experimental vaccine was more than 70% effective at preventing Lyme disease in a trial of nearly 10 ...

Pfizer logo (Photo Illustration by Nikolas Kokovlis/NurPhoto via Getty Images)(NEW YORK) — Earlier this week, pharmaceutical ...

Pfizer said its experimental Lyme disease vaccine was more than 70% efficacious in reducing confirmed cases of the tickborne ...

The companies said the vaccine was 73% effective in reducing the rate of Lyme disease 28 days after the fourth dose.